CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies

BackgroundColorectal cancer (CRC) is a leading cause of cancer-related mortality. CRC incidence and mortality can be reduced by several screening strategies, including colonoscopy, but randomized CRC prevention trials face significant obstacles such as the need for large study populations with long follow-up. Therefore, CRC screening strategies will likely be designed and optimized based on computer simulations. Several computational microsimulation tools have been reported for estimating efficiency and cost-effectiveness of CRC prevention. However, none of these tools is publicly available. There is a need for an open source framework to answer practical questions including testing of new screening interventions and adapting findings to local conditions.MethodsWe developed and implemented a new microsimulation model, Colon Modeling Open Source Tool (CMOST), for modeling the natural history of CRC, simulating the effects of CRC screening interventions, and calculating the resulting costs. CMOST facilitates automated parameter calibration against epidemiological adenoma prevalence and CRC incidence data.ResultsPredictions of CMOST were highly similar compared to a large endoscopic CRC prevention study as well as predictions of existing microsimulation models. We applied CMOST to calculate the optimal timing of a screening colonoscopy. CRC incidence and mortality are reduced most efficiently by a colonoscopy between the ages of 56 and 59; while discounted life years gained (LYG) is maximal at 49–50 years. With a dwell time of 13 years, the most cost-effective screening is at 59 years, at $17,211 discounted USD per LYG. While cost-efficiency varied according to dwell time it did not influence the optimal time point of screening interventions within the tested range.ConclusionsPredictions of CMOST are highly similar compared to a randomized CRC prevention trial as well as those of other microsimulation tools. This open source tool will enable health-economics analyses in for various countries, health-care scenarios and CRC prevention strategies. CMOST is freely available under the GNU General Public License at https://gitlab.com/misselwb/CMOST

[1]  Y. Niv,et al.  Screening Colonoscopy for Colorectal Cancer in Asymptomatic People: A Meta-Analysis , 2008, Digestive Diseases and Sciences.

[2]  Mark P Purdue,et al.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. , 2012, The New England journal of medicine.

[3]  Carolyn M. Rutter,et al.  Clarifying Differences in Natural History between Models of Screening , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  M C Weinstein,et al.  Principles of Cost-Effective Resource Allocation in Health Care organizations , 1990, International Journal of Technology Assessment in Health Care.

[5]  M. Vatn,et al.  Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. , 1986, Scandinavian journal of gastroenterology.

[6]  Walter C Willett,et al.  Diet and cancer: an evolving picture. , 2005, JAMA.

[7]  M. Hochberg,et al.  A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis , 2008, Arthritis research & therapy.

[8]  H. Brenner,et al.  Cost-effectiveness of Colorectal Cancer Screening , 2011, Epidemiologic reviews.

[9]  Ahmedin Jemal,et al.  International Trends in Colorectal Cancer Incidence Rates , 2009, Cancer Epidemiology Biomarkers & Prevention.

[10]  A. Lam,et al.  Synchronous colorectal cancer: clinical, pathological and molecular implications. , 2014, World journal of gastroenterology.

[11]  Iris Lansdorp-Vogelaar,et al.  A Systematic Comparison of Microsimulation Models of Colorectal Cancer , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  Reiko Nishihara,et al.  Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.

[13]  L. Bisanti,et al.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. , 2011, Journal of the National Cancer Institute.

[14]  Harminder Singh,et al.  Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. , 2014, World journal of gastroenterology.

[15]  D. Hüppe,et al.  Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269 000 cases , 2009, European journal of gastroenterology & hepatology.

[16]  James Waterman Glover.  United States Life Tables , 2013 .

[17]  Á. Lanas,et al.  Vorsorge des kolorektalen Karzinoms: Koloskopie oder immunologischer Stuhltest , 2013, Zeitschrift für Gastroenterologie.

[18]  H. Brenner,et al.  Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. , 2010, Journal of the National Cancer Institute.

[19]  Amy B. Knudsen,et al.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. , 2010, Journal of the National Cancer Institute.

[20]  Janneke Wilschut,et al.  At what costs will screening with CT colonography be competitive? A cost‐effectiveness approach , 2009, International journal of cancer.

[21]  A. Neugut,et al.  Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. , 2003, Journal of the National Cancer Institute.

[22]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[23]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[24]  Dl Hoyert,et al.  National Vital Statistics Reports NCHS.pdf , 2012 .

[25]  Amnon Sonnenberg,et al.  Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.

[26]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[27]  Douglas K Rex,et al.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.

[28]  M. Weinstein.  Decision Rules for Incremental Cost-effectiveness Analysis , 2012 .

[29]  Gurkirpal Singh,et al.  Risk of perforation from a colonoscopy in adults: a large population-based study. , 2009, Gastrointestinal endoscopy.

[30]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[31]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[32]  P. Glasziou,et al.  Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update , 2008, The American Journal of Gastroenterology.

[33]  E. Arias,et al.  United States life tables, 2008. , 2012, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[34]  D. Bernardo,et al.  Is right-sided colon cancer different to left-sided colorectal cancer? - a systematic review. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  U. Ladabaum,et al.  Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies , 2013, The American Journal of Gastroenterology.

[36]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[37]  Carolyn M Rutter,et al.  An Evidence-Based Microsimulation Model for Colorectal Cancer: Validation and Application , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[38]  B. Manns,et al.  Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation , 2010, PLoS medicine.

[39]  Jeffrey C. Lagarias,et al.  Convergence Properties of the Nelder-Mead Simplex Method in Low Dimensions , 1998, SIAM J. Optim..

[40]  C. Rutter,et al.  Estimated Mean Sojourn Time Associated with Hemoccult SENSA for Detection of Proximal and Distal Colorectal Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[41]  B. Hemmelgarn,et al.  Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[43]  M. Vatn,et al.  Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. , 1996, Gut.

[44]  L. Bachmann,et al.  Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. , 2012, Gastrointestinal endoscopy.

[45]  C. Iacobuzio-Donahue,et al.  Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[46]  J. Reguła,et al.  Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. , 2006, The New England journal of medicine.

[47]  Linda Rabeneck,et al.  Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. , 2007, Gastroenterology.

[48]  Ann G Zauber,et al.  Individualizing colonoscopy screening by sex and race. , 2009, Gastrointestinal endoscopy.

[49]  P. Maisonneuve,et al.  Smoking and colorectal cancer: a meta-analysis. , 2008, JAMA.

[50]  D. Rockey,et al.  Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  Karen M Kuntz,et al.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. , 2016, JAMA.

[52]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[53]  P. Bossuyt,et al.  Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.

[54]  Angela Mariotto,et al.  Cost of care for elderly cancer patients in the United States. , 2008, Journal of the National Cancer Institute.

[55]  H. Brenner,et al.  Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies , 2007, Gut.

[56]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[57]  S. Saini,et al.  Effect of Flexible Sigmoidoscopy-Based Screening on Incidence and Mortality of Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2012, PLoS medicine.

[58]  B. Levin,et al.  Colorectal cancer screening. Clinical practice guidelines in oncology. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[59]  A. Schoepfer,et al.  Colonoscopic findings of symptomatic patients aged 50 to 80 years suggest that work-up of tumour suspicious symptoms hardly reduces cancer-induced mortality. , 2005, Swiss medical weekly.

[60]  Douglas K Rex,et al.  High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. , 2007, Gastroenterology.

[61]  D W Day,et al.  Polyps and cancer of the large bowel: a necropsy study in Liverpool. , 1982, Gut.

[62]  M. Hernán,et al.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. , 2014, JAMA.

[63]  J. Habbema,et al.  Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. , 2011, Gastroenterology.

[64]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[65]  Joseph A Hill.  United States Life Tables , 2013 .

[66]  Robert H Fletcher,et al.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.